Red blood cell immunization in sickle cell disease: evidence of a large responder group and a low rate of anti-Rh linked to partial Rh phenotype - Wikidata - wikimedia - TriplyDB

Red blood cell immunization in sickle cell disease: evidence of a large responder group and a low rate of anti-Rh linked to partial Rh phenotype

Red blood cell immunization in sickle cell disease: evidence of a large responder group and a low rate of anti-Rh linked to partial Rh phenotype

http://www.wikidata.org/entity/Q41574218

about

How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease.The experience of extended blood group genotyping by next-generation sequencing (NGS): investigation of patients with sickle-cell disease.RH diversity in Mali: characterization of a new haplotype RHD*DIVa/RHCE*ceTI(D2).Prevalence and risk factors for red blood cell alloimmunization in 175 children with sickle cell disease in a French university hospital reference centre.Early occurrence of red blood cell alloimmunization in patients with sickle cell disease.Red blood cell alloimmunization is influenced by the delay between Toll-like receptor agonist injection and transfusion.Changing practice: red blood cell typing by molecular methods for patients with sickle cell disease.TIGIT-positive circulating follicular helper T cells and sickle cell alloimmunization.Severe hemolytic transfusion reaction due to anti-D in a D+ patient with sickle cell disease.Anti-CD20 Antibody Prevents Red Blood Cell Alloimmunization in a Mouse Model.Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease.Anti-HI can cause a severe delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease patients.Immunophenotypic parameters and RBC alloimmunization in children with sickle cell disease on chronic transfusion.Phenotypic differences of CD4(+) T cells in response to red blood cell immunization in transfused sickle cell disease patients.The use of rituximab to prevent severe delayed haemolytic transfusion reaction in immunized patients with sickle cell disease.How I safely transfuse patients with sickle cell disease and manage delayed hemolytic transfusion reactions.Genotyping in Sickle Cell Disease Patients: The French Strategy Rhesus pieces: genotype matching of RBCs

P2860

Q38476241-42DEB32D-AAB9-4B75-80F5-50B05FEFE767 Q38839295-86E0C53A-AA03-4A0D-822A-E7C028687387 Q39019901-1EA850AB-98F3-4630-9C96-2A03C0D2B635 Q40246340-EFD43492-EC28-4FCA-9756-5E884B217BA0 Q40787085-7574482C-776D-4DF1-9F99-9E715917AD09 Q41272014-26316382-695D-4FA9-B84E-983A00F099E0 Q41602202-CA50B2C6-3F2E-4346-A13B-46C58BD7D19C Q42910834-2691BE21-E714-4E1E-BCF6-CBADE9B5D722 Q43153148-78B4668F-34C7-469C-B49D-8B76E05F1E8C Q47621588-2D9193FA-D0F4-4354-BD70-DEEA9D030C7A Q48326469-346EAE87-8E62-433D-92E1-9D963BE78C79 Q50241611-0D946BAD-FD89-4C51-B1C4-5F743A3DCCF7 Q50437265-1469DBB6-D9FA-4288-8918-F381883DC2D0 Q50450148-FA604E08-FCBB-4252-8DA6-F52A46311CE5 Q50454968-2B14F77A-DC27-4BF1-A71F-9EDE45FDB7F2 Q53686375-9E35529C-3579-435B-8BF3-6BC6BF259F0D Q57142948-50F534F8-005A-4D95-A3C1-D3A1C0823230 Q58743555-9E556481-BA20-48CD-983A-226E9875A602

P2860

Red blood cell immunization in sickle cell disease: evidence of a large responder group and a low rate of anti-Rh linked to partial Rh phenotype

http://www.wikidata.org/entity/Q41574218

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Red blood cell immunization in ...... linked to partial Rh phenotype

@en

type

label

Red blood cell immunization in ...... linked to partial Rh phenotype

@en

prefLabel

Red blood cell immunization in ...... linked to partial Rh phenotype

@en

P1433

Q41574218-8ADD6614-6CD1-475E-BFDC-17D7DB0A9E28

P1476

Q41574218-00BF66D6-F2F0-4454-9E53-9D9EA291690A

P2093

Q41574218-1DC562B1-559F-4E57-9444-D28A25102065

Q41574218-40AF0766-4F33-4543-A215-20A4C4630F0C

Q41574218-56F263DB-C08C-4CD7-9957-743752E855F2

Q41574218-6068A29D-09E8-4733-ABD3-741D046E88F0

Q41574218-765DC11E-6AF7-4796-BF10-D812BEE103E7

Q41574218-83C4F5C1-D60C-43E1-A638-13EA3B636717

Q41574218-885F4596-C1CD-4D1A-8FDE-75744C4165E7

Q41574218-C44EB2C6-CBB0-436C-8943-946D7882DC13

Q41574218-C6CD61D4-90CE-4A43-8F8E-4A75DF6D01BE

Q41574218-D4051E7E-B86C-4978-A222-BE0FBA9E0B2C

P2860

Q41574218-29409098-1149-4DF1-B9BC-91C697BDC270

Q41574218-2B6EF675-60E2-4B9B-B5C2-B27303555941

Q41574218-398DF35F-881E-413D-A849-3E84F57327A3

Q41574218-3B652AA1-8641-4EA9-8B98-2A595B389E67

Q41574218-47F878C5-FFE4-45DD-8AB6-9A39325F05EE

Q41574218-4E583B97-0D7F-44F7-B39B-C5B17C9DFA1B

Q41574218-735B794C-A245-4040-A350-2A75FE4D7A3D

Q41574218-77FA12BF-7865-4DE3-93BA-762CC7724AA6

Q41574218-A6864C53-CA74-4C9A-884D-79F3328F2AB6

Q41574218-DF7549D3-CE49-41BD-AB1A-8764499ECF1A

P304

Q41574218-FE297513-3881-46BC-A068-6DFC22263021

P31

Q41574218-45C031C0-BE74-468D-B34C-983EEA0CD94F

P356

Q41574218-5B91DA2C-80CE-4283-9D35-4E2422BF2363

P433

Q41574218-73123FCE-C863-4129-858F-5E380A28263D

P478

Q41574218-DA6FF01C-B7E8-4C89-AD1A-AB7028DE7C52

P577

Q41574218-E6F93040-FBF8-4C5A-9DA7-9925692EA8C1

P698

Q41574218-E3EABC2E-BA0C-43C0-AE20-6B317FD38631

P921

Q41574218-428C2DDE-E812-411D-A3A9-C3C298E5B689

Q41574218-60F1FBB8-B7A9-4C82-8233-6130150E3378

P932

Q41574218-93B128DA-38DF-4B33-B1A7-A274D16054F3

P356

HAEMATOL.2014.104703

P1433

P1476

Red blood cell immunization in ...... linked to partial Rh phenotype

@en

P2093

Christophe Tournamille

http://www.w3.org/2001/XMLSchema#string

France Noizat-Pirenne

http://www.w3.org/2001/XMLSchema#string

Frédéric Galactéros

http://www.w3.org/2001/XMLSchema#string

Jacques Chiaroni

http://www.w3.org/2001/XMLSchema#string

Jérôme Babinet

http://www.w3.org/2001/XMLSchema#string

Monique Silvy

http://www.w3.org/2001/XMLSchema#string

Pascal Bailly

http://www.w3.org/2001/XMLSchema#string

Philippe Bierling

http://www.w3.org/2001/XMLSchema#string

Sadaf Pakdaman

http://www.w3.org/2001/XMLSchema#string

Sylvain Cohen

http://www.w3.org/2001/XMLSchema#string

P2860

Delayed hemolytic transfusion reaction in sickle cell disease

Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management.

Transfusion practices for patients with sickle cell disease at major academic medical centers participating in the Atlanta Sickle Cell Consortium.

Red cell alloimmunization in sickle-cell anaemia patients.

Red blood cell phenotype matching for various ethnic groups.

Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety.

High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors.

The sickle cell hemolytic transfusion reaction syndrome.

Antibody of undetermined specificity: frequency, laboratory features, and natural history.

Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders.

P304

e115-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.2014.104703

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24727821

http://www.w3.org/2001/XMLSchema#string

P921

sickle-cell disease

P932

4077098

http://www.w3.org/2001/XMLSchema#string